Generative AI VC Funding Hits $407B, But OpenAI and Anthropic Take Half

Generative AI startups raised more than $407 billion in venture capital during the first half of 2026, surpassing the $264 billion invested across all of 2025, according to PitchBook’s Q2 2026 AI Report. But behind that record figure lies an extreme concentration: OpenAI and Anthropic together secured about $217 billion—more than half of the six-month total—through just three mega-deals.

For founders, executives and investors worldwide, this is not simply a story of abundant capital. It is a signal that the generative AI market is bifurcating into a small group of frontier labs with near-unlimited access to funding and a much larger field of startups competing for a shrinking pool of deals. Understanding which venture capital firms are writing the largest and earliest checks—and how they operate alongside corporate giants—has become essential to strategic positioning in 2026.

A record half-year built on three deals

OpenAI’s $122 billion round in March was the largest single transaction of the period. Anthropic followed with a $65 billion round in May and a $30 billion round in February, bringing its first-half total to $95 billion. Combined, the two companies accounted for roughly 53% of all generative AI venture funding recorded by PitchBook in H1 2026.

The scale of these rounds has reshaped the market. Total AI startup deal volume fell to only 3,500 transactions in the first half of 2026, down from 8,290 in all of 2025. That decline reflects both investor selectivity amid persistent inflation and higher interest rates, and the gravitational pull of billion-dollar-plus rounds that absorb capital which might previously have been spread across hundreds of earlier-stage deals.

The result is a venture landscape where headline totals can mislead. While the dollar value of AI investment has exploded, the number of companies receiving funding has contracted sharply. For startups outside the frontier model tier, the bar for raising capital has risen even as the total pool has grown.

The VC firms leading generative AI investment

Sequoia Capital remains the most active investor in generative AI, ranking first for the fourth consecutive year, according to PitchBook. The firm has built its position by backing category-defining companies early, with notable investments in OpenAI, Harvey, and Sierra. Its strategy spans foundation models, legal AI, and enterprise automation, giving it exposure across multiple layers of the generative AI stack.

Andreessen Horowitz (a16z) is another dominant force. The firm deploys capital across foundation models, infrastructure, and vertical applications, and it provides deep operational and policy support to founders—an approach that has made it a preferred partner for companies navigating regulatory and go-to-market challenges. Its broad portfolio reflects a belief that value will accrue not only to model builders but also to the tools and applications built on top of them.

Beyond traditional VCs, the funding surge has deepened interdependence between venture investors and strategic corporate backers. Microsoft, Google, and NVIDIA now co-lead many mega-rounds, bringing compute resources, cloud distribution, and strategic partnerships alongside capital. For startups, accepting corporate investment can unlock infrastructure and customers, but it also ties their trajectory to the priorities of large platform companies.

Concentration risks and the open-source counterweight

Critics warn that the extreme concentration of capital in OpenAI and Anthropic risks creating systemic fragility and stifling innovation outside the frontier model tier. If a small number of labs absorb most available funding, the argument goes, the ecosystem becomes vulnerable to a correction if those companies fail to deliver returns or if regulatory or technical shifts undermine their models.

The pressure is already visible among enterprise-focused AI startups. Many are struggling to scale as investors gravitate toward proven frontier labs rather than earlier-stage companies targeting specific industries. At the same time, open-source alternatives are gaining traction in regulated sectors such as finance, healthcare, and government, where data sovereignty, auditability, and cost control matter as much as raw model performance. These open models challenge the dominance of closed, capital-intensive systems and offer a path for startups that cannot raise billions of dollars.

This dynamic is creating a more complex competitive landscape. The frontier labs command enormous resources, but they also face rising expectations. Meanwhile, open-source and vertical AI players are finding room in markets where customisation and control outweigh the benefits of the largest proprietary models.

Strategic implications for founders and executives

For founders, the 2026 funding environment demands a different playbook. Success increasingly depends on aligning with top-tier investors early—firms like Sequoia and a16z that can provide not only capital but also networks, operational guidance, and credibility with later-stage corporate partners. More importantly, startups must demonstrate the potential to become a foundational platform, not just a feature. Investors are asking whether a company can anchor a workflow, own a data moat, or become critical infrastructure, rather than simply adding a generative AI layer to an existing product.

For executives at larger companies, the concentration of capital has strategic consequences. The dominance of a few frontier labs means that enterprise AI strategies may become dependent on a small set of suppliers with enormous funding and influence. At the same time, the rise of open-source models in regulated sectors offers an alternative that can reduce vendor lock-in and improve compliance. Decisions about which models and partners to build on are now as much about long-term risk management as about technical capability.

Investors, too, face a dilemma. The mega-deals in OpenAI and Anthropic offer exposure to the most advanced AI systems, but they also concentrate portfolio risk. The sharp decline in deal volume suggests that many VCs are choosing to write larger checks into fewer companies rather than diversifying across the broader startup ecosystem. Whether that strategy pays off will depend on whether the frontier labs can convert their capital advantage into sustainable revenue and defensible moats.

Looking ahead, the second half of 2026 will test whether the generative AI funding boom broadens beyond its current centre of gravity. If open-source models continue to gain ground in regulated industries and if vertical AI startups can demonstrate clear paths to profitability, investors may begin to spread capital more widely. If not, the market could see further consolidation around a handful of well-capitalised labs and their corporate backers. For founders and executives, the key will be to position for either scenario: build with a clear path to platform status, choose investors and partners strategically, and remain alert to the shifting balance between closed frontier models and open alternatives.